PRICE 2 EARNINGS

Price to Earnings of Idexx Labs




A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z

Price to Earnings analysis of Idexx Labs

08-31-2018

 Price 254.04  USD
 Earnings per share 3.49  USD
 Capitalization (mn) 21,754  USD
 Net income (mn) 304  USD
 P/E ratio 72.80
 Idexx Labs dividend
 Idexx Labs Price to book Value
 Idexx Labs Price to Cash-Flow
 Idexx Labs Return on Equity

Idexx Labs is a Health Care industry firm, which concentrates their activity in the Health Care Equipment and Services sector. Idexx Labs headquarters are in USA, where the firm is listed.

At the time of this analysis, Idexx Labs stocks were trading at a price of 254.04 USD after climbing a 3.70% last month.

According to the chart displayed below, Idexx Labs Price to Earnings Ratio is 72.80, bigger than the amount offered by both firms from USA and fromHealth Care Equipment and Services sector. This high P/E might be a sign of a overvalued company, but also a healthy sign because the market expects growing earnings in the future.Therefore, it is necessary to study Idexx Labs financial situation to reach a conclussion.

Finally, you could compare Idexx Labs P/E with other Health Care Equipment and Services companies or firms from USA.

Idexx Labs price to earnings

Next companies

IDFC. India. Financials.

IDFC Bank. India. Financials.

Idorsia AG. Switzerland. Health Care.

IGM Financial. Canada. Financials.

IHH Healthcare. Malaysia. Health Care.

IHI. Japan. Industrials.

Previous companies

Idemitsu Kosan. Japan. Oil and Gas.

Idea Cellular. India. Telecommunications.

IDBI Bank. India. Financials.

ICICI Prudential Life Insurance. India. Financials.

ICICI Lombard Gral Insurance. India. Financials.

ICICI Bank. India. Financials.

All rights reserved

 information advertisement legal

Dividends Ranking | Price to BookValue | Price to Cash-Flow | Price to Earnings | Return on Equity

Part of Enciclopedia Financiera Group

Disclaimer: Information on this site is only for informational purposes. Always consult a professional advisor before investing.